Percutaneous coronary intervention with ridaforolimus-eluting stents in long lesions: the BIONICS 38 mm prospective trial.

Michael Jonas,Ori Ben-Yehuda,Shmuel Banai,Amit Segev,Haim Danenberg,Abid Assali,Ortal Tuvali,Dan Haberman,Gil Chernin

Coronary artery disease（2023）

引用 0|浏览8

暂无评分

摘要

Percutaneous coronary intervention (PCI) of long lesions with a 38 mm RES achieved satisfactory results, and support the safety and efficacy of PCI with RES in patients with long lesions. (ClinicalTrials.gov NCT03702608).

查看译文

关键词

drug, eluting stent, long coronary lesions, ridaforolimus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要